Jennifer McKenzie
Senior Clinical Program Leader in CRM Boehringer Ingelheim
Seminars
Wednesday 18th March 2026
CKD Trials Across the Age Spectrum: Challenges & Opportunities for Drug Development
10:30 am
- Designing the first global chronic kidney disease trial in children using Jardiance
- Evaluating which clinical trial endpoints are clinically meaningful and acceptable to regulatory authorities for pediatric indications and labeling
- Exploring surrogate biomarkers and adaptive endpoints to reliably gauge efficacy and safety when disease progression is slow
- Maximizing real world data, trial design and drug development programs for future therapies in kidney disease
